Zealand Pharma A/s buy BiotechBee
Start price
01.10.24
/
70%
€109.30
Target price
31.12.27
€150.00
Performance (%)
-2.47%
End price
14.12.24
€106.60
Summary
This prediction ended on 14.12.24 with a price of €106.60. With a performance of -2.47%, the BUY prediction by BiotechBee finished with a loss. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Zealand Pharma A/s | -4.665% | -4.665% | -31.976% |
| iShares Core DAX® | 2,55 % | -0,11 % | 15,00 % |
| iShares Nasdaq 100 | 2,74 % | -0,47 % | 30,95 % |
| iShares Nikkei 225® | 6,58 % | 3,22 % | 49,70 % |
| iShares S&P 500 | 1,93 % | -0,52 % | 24,88 % |
According to BiotechBee what are the pros and cons of Zealand Pharma A/s for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Zealand Pharma A/s diskutieren
Buy mit Kursziel 150,0